EUVIMEDPoznaj EUVIMED
Open access · CC BY 4.0

Clinical application of a modified platelet desialylation test for mechanistic characterization of platelet transfusion refractoriness

Karen Ziza, Thamy Silva, Mateus Domentino, Marina Conrado, João Oliveira, Elyse Moritz, Akemi Chiba, Vanderson Rocha, Alfredo Mendrone-Junior, José Bordin, Langhi Dante iD, Carla Dinardo

Transfusion · 2026-08 · 66 (8) · 1520-1535

DOI: 10.1111/trf.70246 ↗

At a glance

Journal article in Transfusion, published online on 2026-04-29. Written by Karen Ziza and 11 co-authors. Institution: Fundação Pró-Sangue, Hemocentro de São Paulo, São Paulo, São Paulo, Brazil. Major MEDLINE topics: Platelet Transfusion, Blood Platelets, Isoantibodies, Thrombocytopenia. 33 references. The full text is freely available (open access, CC BY 4.0). Funded by: Conselho Nacional de Desenvolvimento Científico e Tecnológico.

AbstraktSubjectsDane bibliograficzneCiteRelated studies

Abstract (original language)

Background

Platelet transfusion refractoriness (PTR) is a major challenge in transfusion medicine and may result from both immune and non‐immune mechanisms. Although alloantibodies are well‐established contributors, Fc‐independent pathways such as platelet desialylation have emerged as alternative mechanisms of clearance. Study Design and Methods In this prospective diagnostic study, 81 patients with suspected PTR were evaluated using an integrated approach combining the platelet immunofluorescence test (PIFT) to detect antibody‐mediated refractoriness and a modified platelet desialylation test (PDT) to assess Fc‐independent clearance. Demographic, clinical, and laboratory variables were analyzed using non‐parametric tests, including Mann–Whitney U , Kruskal–Wallis, and binomial tests.

Results

The cohort exhibited severe thrombocytopenia and diverse clinical profiles. PIFT detected platelet‐bound antibodies in 63/81 cases (78%), while PDT identified desialylation in 41/81 patients (50%). PIFT positivity was similar between PDT‐positive (80.5%) and PDT‐negative (76.9%) groups, with no significant association ( χ 2 = 0.15, p = .69). Although mean fluorescence intensity (MFI) varied across diagnostic categories, no significant differences were observed ( p = .3095). Fever was the only clinical variable significantly associated with reduced desialylation (median MFI 401 vs. 1328.3; p = .0109), while splenomegaly, infection, antifungal use, and bleeding had no significant effects. PDT status was not significantly associated with the number of pooled platelet transfusions ( p = .391) or apheresis procedures ( p = .515), indicating that desialylation alone does not predict transfusion demand.

Discussion

PTR occurs both independently and in parallel with antibody‐mediated pathways. The combined PIFT‐modified PDT approach improves mechanistic characterization and enhances diagnostic accuracy, in cases of platelet refractoriness of immune and non‐immune etiology.

Subjects

MeSH terms (MEDLINE)

Platelet TransfusionBlood PlateletsIsoantibodiesThrombocytopeniaHumansFemaleMaleProspective StudiesMiddle AgedAgedAdult

Author keywords

desialylationplatelet refractorinessplatelet transfusion

Substances

Isoantibodies

Authors and institutions

  • Fundação Pró-Sangue, Hemocentro de São Paulo, São Paulo, São Paulo, Brazil.
  • Department of Hematology, Universidade Federal de São Paulo (UNIFESP), São Paulo, São Paulo, Brazil.
  • Institute of Health Sciences, Universidade Paulista, São Paulo, São Paulo, Brazil.
  • Department of Hematology, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo, São Paulo, Brazil.
  • Churchill Hospital, NHS BT, Oxford University, Oxford, UK.

ORCID profiles: Langhi Dante

Funding

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico

Cite

APA

Ziza, K., Silva, T., Domentino, M., Conrado, M., Oliveira, J., Moritz, E., Chiba, A., Rocha, V., Mendrone-Junior, A., Bordin, J., Dante, L., & Dinardo, C. (2026). Clinical application of a modified platelet desialylation test for mechanistic characterization of platelet transfusion refractoriness. Transfusion, 66(8), 1520-1535. https://doi.org/10.1111/trf.70246

Vancouver

Ziza K, Silva T, Domentino M, Conrado M, Oliveira J, Moritz E, et al. Clinical application of a modified platelet desialylation test for mechanistic characterization of platelet transfusion refractoriness. Transfusion. 2026;66(8):1520-1535. doi:10.1111/trf.70246

BibTeX
@article{Ziza2026,
  author = {Ziza, Karen and Silva, Thamy and Domentino, Mateus and Conrado, Marina and Oliveira, João and Moritz, Elyse and Chiba, Akemi and Rocha, Vanderson and Mendrone-Junior, Alfredo and Bordin, José and Dante, Langhi and Dinardo, Carla},
  title = {Clinical application of a modified platelet desialylation test for mechanistic characterization of platelet transfusion refractoriness},
  journal = {Transfusion},
  year = {2026},
  volume = {66},
  number = {8},
  pages = {1520--1535},
  doi = {10.1111/trf.70246}
}
Start for free →